NASDAQ:ORGO

Organogenesis Holdings . Class A Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy ORGO

*Your capital is at risk

$2.33

+0.0900 (+4.02%)

At Close: Jun 03, 2026

Organogenesis Holdings . Class A Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -1.53. In total, the insiders bought 4.47M and sold 1.37M ORGO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-1.53
● Buy	4.47M shares
● Sell	1.37M shares
48% Buy Activity Moderate Positive Correlation
Buy Signal Low Confidence Feb 18, 2026 Analysis Breakdown: Weakened by a contradictory negative Insider Power Score. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 15, 2026 Sell	Class A Common Stock F-InKind	Montecalvo Antonio S. Vice President, Health Policy	CEO / President	3 523 Value: $13.1K
Feb 15, 2026 Sell	Class A Common Stock F-InKind	Grow Brian Chief Commercial Officer	Officer	11 144 Value: $41.6K
Feb 15, 2026 Sell	Class A Common Stock F-InKind	Grow Brian Chief Commercial Officer	Officer	18 910 Value: $70.5K
Feb 15, 2026 Sell	Class A Common Stock F-InKind	Gillheeney Gary S. President And CEO	CEO / President	85 605 Value: $319.3K
Feb 15, 2026 Sell	Class A Common Stock F-InKind	Gillheeney Gary S. President And CEO	CEO / President	78 646 Value: $293.3K
Feb 15, 2026 Sell	Class A Common Stock F-InKind	Freedman Lori Chief Admin. And Legal Officer	Officer	13 510 Value: $50.4K
Feb 15, 2026 Sell	Class A Common Stock F-InKind	Freedman Lori Chief Admin. And Legal Officer	Officer	24 428 Value: $91.1K
Dec 16, 2025 Sell	Class A Common Stock S-Sale	Nussdorf Glenn H Director	Director	200 000 Value: $1.03M
Nov 26, 2025 Sell	Class A Common Stock S-Sale	Nussdorf Glenn H	Director	187 957 Value: $994.3K
Nov 25, 2025 Sell	Class A Common Stock S-Sale	Nussdorf Glenn H	Director	12 043 Value: $63.8K
Nov 24, 2025 Sell	Class A Common Stock S-Sale	Nussdorf Glenn H	Director	100 000 Value: $534.0K
Aug 11, 2025 Buy	Class A Common Stock M-Exempt	Grow Brian Chief Commercial Officer	Officer	4 060 Value: $10.0K
Aug 11, 2025 Sell	Class A Common Stock F-InKind	Grow Brian Chief Commercial Officer	Officer	2 173 Value: $10.0K
Aug 11, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Grow Brian Chief Commercial Officer	Officer	4 060 Value: $10.0K
Aug 11, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Grow Brian Chief Commercial Officer	Officer	4 060 Value: $10.0K
Aug 11, 2025 Sell	Class A Common Stock F-InKind	Grow Brian Chief Commercial Officer	Officer	2 173 Value: $10.0K
Aug 11, 2025 Buy	Class A Common Stock M-Exempt	Grow Brian Chief Commercial Officer	Officer	4 060 Value: $10.0K
Jul 16, 2025 Sell	Class A Common Stock F-InKind	Cavorsi Robert Vice President, Strategy	CEO / President	360 Value: $2K
Jul 16, 2025 Sell	Class A Common Stock F-InKind	Cavorsi Robert Vice President, Strategy	CEO / President	360 Value: $2K
Jun 10, 2025 Sell	Class A Common Stock S-Sale	Nussdorf Glenn H	Director	18 620 Value: $66.3K
Jun 09, 2025 Sell	Class A Common Stock S-Sale	Nussdorf Glenn H	Director	4 156 Value: $14.5K
May 15, 2025 Buy	Class A Common Stock P-Purchase	Nussdorf Glenn H	Director	107 494 Value: $321.0K
May 14, 2025 Buy	Class A Common Stock P-Purchase	Nussdorf Glenn H	Director	251 001 Value: $775.0K
Jan 10, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Grow Brian Chief Commercial Officer	Officer	958 Value: $1K
Jan 10, 2025 Buy	Class A Common Stock M-Exempt	Grow Brian Chief Commercial Officer	Officer	958 Value: $1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ORGANOGENESIS HOLDINGS INC. CLASS A

Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy ...

Read Full Profile Here